{{medical}}
{{citation style|time=2018-04-28T04:08:14+00:00}}
{{expert|time=2010-12-13T07:30:07+00:00}}
{{noteTA
|T=zh-cn:泼尼松龙; zh-tw:康速龍錠;
|1=zh-cn:泼尼松龙; zh-tw:康速龍錠;
}}
{{drugbox
| verifiedrevid = 395152746
| IUPAC_name = (11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
|synonyms = <small>11,17-dihydroxy-17- (2-hydroxyacetyl)- 10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17- dodecahydrocyclopenta [a]phenanthren-3-one</small>
| image = Prednisolone-2D-skeletal.svg
| image2 = Prednisolone-3D-balls.png
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9PHQ9Y1OLM
| InChI1 = 1/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1
| InChIKey1 = OIGNJSKKLXVSLS-VWUMJDOOBF
| smiles = O=C\1\C=C/[C@]4(/C(=C/1)CC[C@@H]2[C@@H]4[C@@H](O)C[C@@]3([C@@](O)(C(=O)CO)CC[C@@H]23)C)C
| CAS_number = 50-24-8
| CAS_number_Ref = {{cascite|correct|CAS}}
| ChemSpiderID = 5552
| ATC_prefix = A07
| ATC_suffix = EA01
| ATC_supplemental = {{ATC|C05|AA04}}, {{ATC|D07|AA03}}, {{ATC|D07|XA02}}, {{ATC|H02|AB06}}, {{ATC|R01|AD02}}, {{ATC|S01|BA04}}, {{ATC|S01|CB02}}, {{ATC|S02|BA03}}, {{ATC|S03|BA02}}
| PubChem = 5755
| IUPHAR_ligand = 2866
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00860
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00472
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8378
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 131
| C=21 | H=28 | O=5
| molecular_weight = 360.444 g/mol
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 2-3 小時
| excretion = 潑尼松發經由尿液排泄
| pregnancy_AU = A
| pregnancy_US = C
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = 
}}

'''泼尼松龙'''（{{lang-en|'''Prednisolone'''}}），又译作'''康速龍錠'''（{{lang-en|Donison}}），是一種合成之副腎皮質荷爾蒙製劑，也是一種[[皮質類固醇|皮質類固醇]]<ref name=miaoli>{{cite web |url=http://web.mil.doh.gov.tw/drug/file/P/Prednisone.pdf |title=Prednisolone用藥指導單張 |language=zh-hant |publisher=[[苗栗醫院|苗栗醫院]] |accessdate=2012-02-28 |deadurl=yes |archiveurl=https://web.archive.org/web/20120417024820/http://web.mil.doh.gov.tw/drug/file/P/Prednisone.pdf |archivedate=2012-04-17 }}</ref>藥物，是[[潑尼松|潑尼松]]的一種[[活性代謝產物|活性代謝產物]]<ref name="Davis">{{cite journal| author = Davis M, Williams R, Chakraborty J, ''et al.''| title = Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability| journal = British Journal of Clinical Pharmacology| volume = 5| issue = 6| pages = 501–5| pmid = 656293| pmc = 1429358|date=June 1978}}</ref>，同時亦作為藥物使用。它主要對[[糖皮質激素|糖皮質激素]]活躍，[[礦物類皮質激素|礦物類皮質激素]]活性低，使其適用於廣泛的[[炎症|炎症]]及[[自體免疫|自體免疫]]狀況<ref name=Pharmacokinet>Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61-98. Review. PMID 15634032</ref>，例如：[[哮喘|哮喘]]<ref>Fiel SB, Vincken W. Systemic corticosteroid therapy for acute asthma exacerbations. J Asthma. 2006 Jun-Jul;43(5):321-31. Review. PMID 16801135</ref>、[[葡萄膜炎|葡萄膜炎]]、[[壞疽性膿皮病|壞疽性膿皮病]]、[[類風濕關節炎|類風濕關節炎]]、[[潰瘍性結腸炎|潰瘍性結腸炎]]、[[顳動脈炎|顳動脈炎]]及[[克羅恩病|克羅恩病]]、[[貝爾氏麻痺|貝爾氏麻痺]]、[[多發性硬化症|多發性硬化症]]<ref>Thrower BW. Relapse management in multiple sclerosis. Neurologist. 2009 Jan;15(1):1-5. Review. PMID 19131851</ref>、[[叢集性頭痛|叢集性頭痛]]、[[血管炎|血管炎]]、[[急性淋巴細胞白血病|急性淋巴細胞白血病]]和[[自身免疫性肝炎|自身免疫性肝炎]]<ref>Lambrou GI, Vlahopoulos S, Papathanasiou C, Papanikolaou M, Karpusas M, Zoumakis E, Tzortzatou-Stathopoulou F. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression. Leuk Res. 2009 May 16. [Epub ahead of print] PMID 19450877</ref>、[[系統性紅斑狼瘡|系統性紅斑狼瘡]]、[[皮肌炎|皮肌炎]]。它也被用於治療[[類肉瘤病|類肉瘤病]]<ref>{{cite web |url=http://blog.udn.com/jnwu/3302280 |title=類肉瘤病 Sarcoidosis |date=2009-09-09 |accessdate=2012-02-28 |language=zh-hant}}</ref>，但機制不明。

==常見副作用==
腸胃不適 食慾改變 消化不良 過敏 

臨床應用常與胃乳 制酸劑一同使用

==藥理==
抗發炎用藥及其他用途

==副作用==
可能的副作用包含了[[水腫|水腫]]的臉（滿月臉，[[庫興氏症候群|庫興氏症候群]]）。能夠使[[糖尿病|糖尿病]]患者的血糖上升。

==運動員禁用==
是一種糖皮質激素，根據[[国际反兴奋剂组织|WADA]]的反興奮劑規則，類固醇是被禁止使用的。<ref>{{Cite web |title=The 2008 Prohibited List}}    {{cite web |url=http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf |title=存档副本 |accessdate=2007-10-30 |deadurl=yes |archiveurl=https://web.archive.org/web/20071030051804/http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf |archivedate=2007-10-30 }}</ref>根据“[[奇幻熊|奇幻熊]]”网站于2016年10月3日公布的最新一份解密，[[日本|日本]][[乒乓球|乒乓球]][[运动员|运动员]][[福原爱|福原爱]]在2016年5月18日至6月17日期间曾在[[国际乒联|国际乒联]]的许可下获得了该药的“[[治疗用药豁免权|治疗用药豁免权]]”。

==藥劑品名==
*"柏理"康速龍錠，5毫克，（陪尼皮質醇），臺灣"應元化學製藥公司"（柏理公司委托）。Compesolon Tablets 5mg "Pine Lawer" (Prednisolone).

==參考文獻==
{{Reflist}}

==外部連結==
*[http://www.chimei.org.tw/main/right/right01/cmh_department/55500/guide/08.prednisolone.pdf Prednisolone 樂爾爽片®]{{dead link|date=2018年3月 |bot=InternetArchiveBot |fix-attempted=yes }}

{{Template:血管保护药}}
{{Otologicals}}

[[Category:糖皮质激素|Category:糖皮质激素]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:耳科用药|Category:耳科用药]]